Highlights Viking Therapeutics, Inc.

Equities

VKTX

US92686J1060

Market Closed - Nasdaq Other stock markets 21:00:00 20/06/2024 BST			5-day change	1st Jan Change
50.43 ^USD	-0.41%		-3.21%	+170.98%

06-04	Health Care Climbs on Defensive Bias - Health Care Roundup	DJ
06-04	Sector Update: Health Care Stocks Steady Pre-Bell Tuesday	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Health Care Climbs on Defensive Bias - Health Care Roundup	06-04	DJ
Sector Update: Health Care Stocks Steady Pre-Bell Tuesday	06-04	MT
Viking Therapeutics Reports 'Positive' 52-Week Results for NASH Drug; Shares Rise Pre-Bell	06-04	MT
Viking Therapeutics Announces Positive 52-Week Histologic Data from Phase 2B Voyage Study of Vk2809 in Patients with Biopsy-Confirmed Non-Alcoholic Steatohepatitis	06-04	CI
North American Morning Briefing : The "Everything -2-	05-17	DJ
Amgen shares jump after teasing weight-loss drug data, rivals slip	05-03	RE
Sector Update: Health Care Stocks Lean Lower Pre-Bell Thursday	04-25	MT
Tranche Update on Viking Therapeutics, Inc.'s Equity Buyback Plan announced on April 27, 2022.	04-25	CI
Viking Therapeutics Q1 Loss Widens; Shares Fall After Hours	04-24	MT
Viking Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-24	CI
Health Care Falls as Risk Aversion Weighs on Obesity Drug Makers -- Health Care Roundup	04-12	DJ
Health Care Down on Flight From Risk -- Health Care Roundup	04-02	DJ
Health Care Down as Obesity-Drug Optimism Fades -- Health Care Roundup	04-01	DJ
Viking Therapeutics Reports 'Positive Results' in Study of Potential Obesity Drug; Shares Jump	03-26	MT
PE firm Olympus to sell 9.8% stake in India's Aster DM Healthcare for up to $234.5 million, term sheet shows	03-26	RE
Viking Therapeutics Announces Results from Phase 1 Clinical Trial of Oral Tablet Formulation of Dual GLP-1/GIP Receptor Agonist VK2735	03-26	CI
Viking Therapeutics, Inc. 's Equity Buyback announced on March 10, 2022 has expired with repurchase of 729,034 shares, representing 0.94% for $1.66 million.	03-17	CI
Health Care Up on Strong Earnings -- Health Care Roundup	02-29	DJ
Global markets live: Reckitt, Apple, Warner, Eli Llily, Intel...	02-28
Stocks in motion: eBay, Viking Therapeutics and UnitedHealth	02-28

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Viking Therapeutics, Inc.

Equities

VKTX

US92686J1060

Highlights

Filters